Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Christopher D. Alafi | Director | $377M | May 27, 2021 | ||
Sharon Mates | Chairman and CEO, Director | $92M | -$35.6M | -27.9% | Dec 4, 2024 |
Rory Riggs | Director | $11M | -$337K | -2.98% | Dec 31, 2024 |
Richard A. Lerner | Director | $7.16M | Sep 30, 2021 | ||
Joel S. Marcus | Director | $3.87M | -$1.81M | -31.8% | Jun 23, 2024 |
Mark Neumann | EVP, Chief Commercial Officer | $2.72M | -$3.32M | -54.9% | Aug 16, 2024 |
Sanjeev Narula | Executive Vice President & CFO | $2.4M | Aug 12, 2024 | ||
Suresh K. Durgam | EVP, Chief Medical Officer | $1.82M | -$961K | -34.6% | Mar 7, 2024 |
Robert L. Van Nostrand | Director | $777K | -$2.98M | -79.3% | Jun 28, 2024 |
Michael Halstead | President | $537K | -$5.6M | -91.2% | Nov 12, 2024 |
Lawrence J. Hineline | SVP of Finance, CFO | $372K | -$2.47M | -86.9% | Mar 7, 2024 |
Eduardo Rene Salas | Director | $118K | Jun 23, 2024 | ||
Michael Rawlins | Director | Jun 9, 2022 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|